np event 2254995 0E193A 1
Jul 30, 2024
- Jul 29, 2025
The Emerging Role of Activin Signaling Inhibitor Therapeutics to Improve Outcomes for Patients with PAH
1.0

Claim your credit

Already have an Account? Log In
Don’t have an account? Register Today

 Claim your Certificate

Related Courses

Group 39553
Cardiometabolic
ATTR-CM : Updated epidemiology, diagnosis, sex disparities and latest TTR stabilizer data ...
Group 39553
Women's Health
Pain Management in Endometriosis: A Primer for NPs and PAs
Group 39553
Nephrology
The (Busy!) Year in Review: The Emergence of Aldosterone Synthase Inhibitors for Difficult...